The novel therapy of the medication represents a major advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide031617.blogofoto.com/73506286/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment